Six more biotechs price public debuts just before the start of the weekend

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.

Another six biotechs priced IPOs on Thursday and Friday, joining this week’s big rush to Wall Street. Biotech companies have raised more than $11.7 billion so far this year, closing in on last year’s record $16.5 billion raise.

Scroll down for everything you need to know about the latest companies hitting Nasdaq.

Tenaya Therapeutics catches IPO window months after crossover round

Upon pulling in a $106 million crossover round back in March, Tenaya Therapeutics CEO Faraz Ali told Endpoints News that the company wasn’t planning on “opportunistically trying to catch an IPO window” — that they’d wait until the science was ready.

On Thursday, the company priced a $180 million IPO, offering an upsized 12 million shares at $15 apiece (the midpoint of a $14 to $16 range).

Tenaya had initially filed…
Click here to view original post